Participants 39 132 4
recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia.
Participants 134 351 7
Thirty-three patients with II type mixed essential cryoglobulinemia (MEC) were randomized into two groups: one to receive combined therapy including prednisone plus interferon, the other to receive prednisone therapy.
Participants 1430 1511 3
maintenance treatment in the therapy of II type mixed essential cryoglobulinemia.
